Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | ARNOLD & PORTER KAYE SCHOLER LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| ARNOLD & PORTER KAYE SCHOLER LLP | 3 | — |
| Issue | Activities |
|---|---|
| Medicare/Medicaid | 3 |
| Health Issues | 3 |
| Trade (domestic/foreign) | 3 |